C-PATH Trademark

Trademark Overview

On Wednesday, August 6, 2014, a trademark application was filed for C-PATH with the United States Patent and Trademark Office. The USPTO has given the C-PATH trademark a serial number of 86358787. The federal status of this trademark filing is REGISTERED AND RENEWED as of Monday, October 6, 2025. This trademark is owned by The Critical Path Institute (C-Path). The C-PATH trademark is filed in the Advertising, Business and Retail Services category with the following description:

Promoting collaboration between scientists and university institutions to facilitate innovation in the drug development process
c-path

General Information

Serial Number86358787
Word MarkC-PATH
Filing DateWednesday, August 6, 2014
Status800 - REGISTERED AND RENEWED
Status DateMonday, October 6, 2025
Registration Number4816134
Registration DateTuesday, September 22, 2015
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 7, 2015

Trademark Statements

Pseudo MarkCRITICAL-PATH
Goods and ServicesPromoting collaboration between scientists and university institutions to facilitate innovation in the drug development process

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateWednesday, May 6, 2015
Primary Code035
First Use Anywhere DateFriday, December 3, 2004
First Use In Commerce DateFriday, December 3, 2004

Trademark Owner History

Party NameThe Critical Path Institute (C-Path)
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressTucson, AZ 85718
Party NameThe Critical Path Institute (C-Path)
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressTucson, AZ 85718
Party NameThe Critical Path Institute (C-Path)
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressTucson, AZ 85718

Trademark Events

Event DateEvent Description
Saturday, August 9, 2014NEW APPLICATION ENTERED
Thursday, August 14, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, August 15, 2014NOTICE OF PSEUDO MARK E-MAILED
Wednesday, November 19, 2014ASSIGNED TO EXAMINER
Tuesday, November 25, 2014NON-FINAL ACTION WRITTEN
Tuesday, November 25, 2014NON-FINAL ACTION E-MAILED
Tuesday, November 25, 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, May 6, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, May 6, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, May 6, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, May 8, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 3, 2015ASSIGNED TO LIE
Wednesday, June 3, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, June 17, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 7, 2015PUBLISHED FOR OPPOSITION
Tuesday, July 7, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 22, 2015REGISTERED-PRINCIPAL REGISTER
Tuesday, September 22, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, April 12, 2021TEAS SECTION 8 & 15 RECEIVED
Tuesday, August 10, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, August 27, 2021REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, August 27, 2021NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Sunday, September 22, 2024COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Wednesday, April 9, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, April 9, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, April 9, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, June 13, 2025TEAS SECTION 8 & 9 RECEIVED
Monday, October 6, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, October 6, 2025REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Monday, October 6, 2025REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Monday, October 6, 2025NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

Related Keywords

path innovation drug development process facilitate institutions collaboration between scientists university